Cresco Labs Inc. (CRLBF) Form 10-Q Quarterly Reports
Cresco Labs Inc. (CRLBF) is a publicly traded company on the OTC, categorized under SIC 2833 (Medicinal Chemicals & Botanical Products). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CRLBF
CIK: 1832928
Exchange: OTC
SIC 2833: Medicinal Chemicals & Botanical Products
Fiscal Year End: 12/31
State: A1
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Baker Tilly US, LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJeffrey Smith
Audit LocationChicago, Illinois, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-13 | 2026-10-13 | 6-K | 0001832928-26-000014 | View SEC Doc Filr Page |
| 6-K | 2026-09-30 | 2026-09-30 | 6-K | 0001832928-26-000012 | View SEC Doc Filr Page |
| 6-K | 2026-08-06 | 2026-06-30 | 6-K | 0001832928-26-000010 | View SEC Doc Filr Page |
| 6-K | 2026-05-08 | 2026-03-31 | 6-K | 0001832928-26-000008 | View SEC Doc Filr Page |
| 40-F | 2026-03-06 | 2025-12-31 | 40-F | 0001832928-26-000005 | View SEC Doc Filr Page |
| 6-K | 2026-02-02 | 2026-01-30 | 6-K | 0001832928-26-000003 | View SEC Doc Filr Page |
| EFFECT | 2025-12-11 | — | EFFECT Filing | 9999999995-25-003663 | View SEC Doc Filr Page |
| 6-K | 2025-11-07 | 2025-11-07 | 6-K | 0001832928-25-000038 | View SEC Doc Filr Page |
| F-X | 2025-10-06 | — | F-X | 0001832928-25-000033 | View SEC Doc Filr Page |
| F-10 | 2025-10-06 | — | F-10 | 0001832928-25-000031 | View SEC Doc Filr Page |
| 6-K | 2025-09-22 | 2025-09-22 | 6-K | 0001832928-25-000028 | View SEC Doc Filr Page |
| SC TO-I/A | 2025-09-18 | — | SC TO-I/A | 0001832928-25-000026 | View SEC Doc Filr Page |
| 6-K | 2025-09-17 | 2025-09-16 | 6-K | 0001832928-25-000024 | View SEC Doc Filr Page |
| SC TO-I | 2025-08-20 | — | SC TO-I | 0001832928-25-000022 | View SEC Doc Filr Page |
| SC TO-C | 2025-08-20 | — | SC TO-C | 0001832928-25-000020 | View SEC Doc Filr Page |
| 6-K | 2025-08-15 | 2025-08-15 | 6-K | 0001832928-25-000018 | View SEC Doc Filr Page |
| 6-K | 2025-08-07 | 2025-08-07 | 6-K | 0001832928-25-000016 | View SEC Doc Filr Page |
| 6-K | 2025-06-13 | 2025-06-12 | 6-K | 0001832928-25-000013 | View SEC Doc Filr Page |
| 6-K | 2025-05-30 | 2025-05-30 | 6-K | 0001832928-25-000009 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-05-15 | — | SCHEDULE 13G/A Filing | 0000905148-25-001772 | View SEC Doc Filr Page |
| 40-F | 2025-03-14 | 2024-12-31 | 40-F | 0001832928-25-000006 | View SEC Doc Filr Page |
| 6-K | 2025-03-12 | 2025-03-12 | 6-K | 0001832928-25-000002 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2025-02-14 | — | SCHEDULE 13G Filing | 0000902664-25-001027 | View SEC Doc Filr Page |
| SC 13G/A | 2024-11-14 | — | SC 13G/A Filing | 0000905148-24-003172 | View SEC Doc Filr Page |
| 6-K | 2024-11-12 | 2024-11-08 | 6-K | 0001832928-24-000060 | View SEC Doc Filr Page |